Business Context and Reporting Period
This Form 8-K filing by Crawford & Company reports a corporate governance event occurring on July 31, 2018, with the report filed on August 2, 2018. The filing focuses on the election of a new independent director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific event and does not contain financial statement data.
Material Changes
The material change reported is the appointment of Michelle Jarrard as an independent Director. There are no reported changes to financial performance or operational metrics in this document.
Guidance, Outlook, and Management Commentary
- Director Appointment: Michelle Jarrard, age 51, was unanimously elected as an independent Director.
- Background: Ms. Jarrard is a senior advisor to the GRA Venture Fund and formerly served as Global Chief HR and Talent Officer of McKinsey & Company (2007–2016). She currently serves on the boards of Lazard Ltd, Axion Biosystems, QUEST Renewables, and Children's Healthcare of Atlanta.
- Committee Assignment: Ms. Jarrard will serve as a member of the Compensation Committee.
- Compensation: She will receive standard compensation for non-employee directors. Her 2018 annual compensation, including an initial equity grant, will be pro-rated to reflect her partial term.
- Related Party Transactions: The filing states there are no arrangements or transactions involving Ms. Jarrard or her immediate family requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the press release attached as Exhibit 99.1 for additional details on the appointment.
- Confirm the pro-rated compensation structure for partial-year director appointments in the company's proxy statement.
- Review the composition of the Compensation Committee to understand the impact of the new appointment.